Neuphoria Therapeutics Inc.

For the period ended Jun 30, 2026. Filed Sep 18, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Sep 18, 2026

NEUP$2.78+0.4%Stored close · as of Nov 6, 2026

Opening this filing…